June 1, 2025

Overview
President Donald Trump recently addressed allegations of drug use by Elon Musk, his former advisor and head of the Department of Government Efficiency (DOGE), during a May 30, 2025, press conference. The remarks followed a New York Times report claiming Musk consumed ketamine, ecstasy, and psychedelic mushrooms while campaigning for Trump in 2024. Concurrently, Trump has referenced a 2023 incident involving cocaine found at the White House under President Joe Biden, suggesting it may warrant further investigation. These developments have sparked public debate about transparency, accountability, and the conduct of high-profile government figures, reflecting broader societal concerns about trust in leadership.

Facts

• President Trump previously stated he was unaware of Musk’s alleged drug use, but thinks Musk is “fantastic,” and emphasized that Musk “did a great job” with DOGE.
• A New York Times report published on May 30, 2025, alleged Musk used ketamine, ecstasy, and psychedelic mushrooms during Trump’s 2024 campaign, citing anonymous sources familiar with Musk’s activities.
• Musk responded on May 30, 2025, during a press conference, saying, “Is that the same publication that got a Pulitzer Prize for false reporting on the Russiagate? Let’s move on.”
• On July 2, 2023, during the Biden Administration, the U.S. Secret Service discovered a small bag of cocaine in a storage locker near the White House’s West Wing entrance.
• The Secret Service closed its investigation on July 13, 2023, stating, “There was no surveillance video footage found that provided investigative leads or any other means for investigators to identify who may have deposited the found substance in this area.”
• In May 2025, FBI Deputy Director Dan Bongino announced the FBI is reexamining the 2023 cocaine incident.
• Trump commented on March 1, 2025, in an interview, “I believe either Joe or Hunter [Biden]” left the cocaine, noting the locker was “wiped dry” despite typically having “hundreds and even thousands of fingerprints.”
• On September 6, 2018, during an appearance on The Joe Rogan Experience podcast, Musk smoked marijuana, taking a drag from a blunt containing tobacco and marijuana offered by host Joe Rogan. Musk stated, “I’m not a regular smoker of weed,” and asked, “I mean it’s legal, right?” before smoking.
• The podcast was recorded in California, where recreational marijuana was legal, but marijuana use remains a federal crime.
• In 2022, Musk told the Full Send podcast, “I had to have like random drug tests and stuff after that, to prove that I’m not like a drug addict,” confirming he underwent three years of random drug testing at NASA’s request, with no trace of drugs or alcohol found.
• On May 31, 2025, Musk posted on 𝕏, “Also, to be clear, I am NOT taking drugs! … I tried prescription ketamine a few years ago and said so on 𝕏.”

Perspectives

• President Donald Trump: Supports Musk’s contributions to DOGE, dismissing concerns about alleged drug use as irrelevant to his performance. Trump emphasizes Musk’s patriotism and suggests the cocaine found in 2023 implicates the Biden family, calling for renewed scrutiny.
• Elon Musk: Rejects the drug use allegations by questioning the credibility of the reporting source. Musk frames his DOGE tenure as a successful effort to reduce government waste, vowing to continue advising Trump informally.
• Biden Administration (via 2023 statements): Maintained the cocaine incident occurred in a high-traffic area when the Biden family was at Camp David, with no evidence linking them to the substance. The administration prioritized closing the matter due to inconclusive evidence.

Considerations

• Allegations of drug use by high-profile advisors like Musk could erode public trust in government vetting processes, especially amid declining confidence in institutions.
• The reopening of the 2023 cocaine investigation may signal heightened political accountability efforts but risks being perceived as partisan if not supported by new evidence.
• Short-term public focus on personal conduct may overshadow DOGE’s long-term impact on federal spending and agency operations.
• Increased scrutiny of advisors’ backgrounds could lead to stricter vetting policies for special government employees in future administrations.
• The contrast between Musk’s corporate drug-free policies and alleged personal use highlights tensions in balancing private conduct with public roles.
• Public policy debates may shift toward stronger oversight of unelected advisors wielding significant influence over government operations.

© Copyright 2025, CAPY News LLC, All Rights Reserved. This article includes content produced using advanced software with human instruction and oversight.